NYMOX PHARMACEUTICAL CORP Insider Trading for November 2018

FREE EMAIL WATCHDOG

Get free email notifications about insider trading in NYMOX PHARMACEUTICAL CORP.

  • Your email is safe with us.
  • The service is free and you can unsubscribe at any time.

General | Insiders | Insider Transactions | Monthly Overview | Weekly Overview


Overview of insider trading in NYMOX PHARMACEUTICAL CORP for November 2018.

<<< Back to the month list

DateTickerCompanyOwnerRelationship Transaction Code Cost ($) Shares Transaction Value ($) Total Shares % Holdings
Nov 30 2018NYMXNYMOX PHARMACEUTIC ...Robinson James GeorgeDirectorBuyP1.817,00012,6603,265,9133.3 M to 3.3 M (+0.21 %)
Nov 28 2018NYMXNYMOX PHARMACEUTIC ...Robinson James GeorgeDirectorBuyP1.718,00013,6793,258,9133.3 M to 3.3 M (+0.25 %)
Nov 21 2018NYMXNYMOX PHARMACEUTIC ...Robinson James GeorgeDirectorBuyP1.786,00010,7063,250,9133.2 M to 3.3 M (+0.18 %)
Nov 21 2018NYMXNYMOX PHARMACEUTIC ...Robinson James GeorgeDirectorBuyP1.749,00015,6753,244,9133.2 M to 3.2 M (+0.28 %)
Nov 21 2018NYMXNYMOX PHARMACEUTIC ...Robinson James GeorgeDirectorBuyP1.936,00011,5803,235,9133.2 M to 3.2 M (+0.19 %)
Nov 15 2018NYMXNYMOX PHARMACEUTIC ...Robinson James GeorgeDirectorBuyP2.007,00013,9943,229,9133.2 M to 3.2 M (+0.22 %)
Nov 13 2018NYMXNYMOX PHARMACEUTIC ...Robinson James GeorgeDirectorBuyP2.147001,4953,222,9133.2 M to 3.2 M (+0.02 %)
Nov 13 2018NYMXNYMOX PHARMACEUTIC ...Robinson James GeorgeDirectorBuyP2.126,30013,3743,222,2133.2 M to 3.2 M (+0.20 %)
Nov 13 2018NYMXNYMOX PHARMACEUTIC ...Robinson James GeorgeDirectorBuyP2.065,57311,4793,215,9133.2 M to 3.2 M (+0.17 %)
Nov 13 2018NYMXNYMOX PHARMACEUTIC ...Robinson James GeorgeDirectorBuyP2.061002063,210,3403.2 M to 3.2 M (0.00 %)
Nov 13 2018NYMXNYMOX PHARMACEUTIC ...Robinson James GeorgeDirectorBuyP2.053276703,210,2403.2 M to 3.2 M (+0.01 %)
Nov 09 2018NYMXNYMOX PHARMACEUTIC ...Robinson James GeorgeDirectorBuyP2.043637403,209,9133.2 M to 3.2 M (+0.01 %)
Nov 06 2018NYMXNYMOX PHARMACEUTIC ...Averback PaulCEOSellS1.75100,000175,00023,331,44823.4 M to 23.3 M (-0.43 %)
Nov 06 2018NYMXNYMOX PHARMACEUTIC ...Averback PaulCEOSellS2.501,687,6004,219,00021,643,94823.3 M to 21.6 M (-7.23 %)
Nov 06 2018NYMXNYMOX PHARMACEUTIC ...LANHAM RANDALL JGeneral CounselBuyP1.722,9004,988152,900150 K to 152.9 K (+1.93 %)
Nov 06 2018NYMXNYMOX PHARMACEUTIC ...Robinson James GeorgeDirectorBuyP1.981,0502,0793,209,5503.2 M to 3.2 M (+0.03 %)
Nov 06 2018NYMXNYMOX PHARMACEUTIC ...Robinson James GeorgeDirectorBuyP1.984,1508,2173,208,5003.2 M to 3.2 M (+0.13 %)
Nov 06 2018NYMXNYMOX PHARMACEUTIC ...Robinson James GeorgeDirectorBuyP1.971,8003,5463,204,3503.2 M to 3.2 M (+0.06 %)
Nov 02 2018NYMXNYMOX PHARMACEUTIC ...Robinson James GeorgeDirectorBuyP1.906,00011,4003,202,5503.2 M to 3.2 M (+0.19 %)
Nov 02 2018NYMXNYMOX PHARMACEUTIC ...Robinson James GeorgeDirectorBuyP1.906,00011,4003,202,5503.2 M to 3.2 M (+0.19 %)
Nov 01 2018NYMXNYMOX PHARMACEUTIC ...Robinson James GeorgeDirectorBuyP1.796,00010,7333,196,5503.2 M to 3.2 M (+0.19 %)
Nov 01 2018NYMXNYMOX PHARMACEUTIC ...Robinson James GeorgeDirectorBuyP1.796,00010,7663,190,5503.2 M to 3.2 M (+0.19 %)
Nov 01 2018NYMXNYMOX PHARMACEUTIC ...Robinson James GeorgeDirectorBuyP1.786,00010,6653,184,5503.2 M to 3.2 M (+0.19 %)